Reliable, Efficient, Knowledgeable

A team of expert consultants in regulatory affairs

Starodub consultants partner with (bio)pharmaceutical and medical device companies to ensure that regulatory requirements are met and business goals are achieved.

We will support you in developing and registering your medicinal product(s), such as small molecules, biologics, biotechnology derived products, and vaccines

We support the development and registration of your medical devices , such as class I to class III devices, including software, in vitro diagnostic and drug-device combination products worldwide

To make sure that your application conforms with all other requirements beside the scientific requirements, we support regulatory operations and provide publishing services

Who are we?

Starodub aims to be your strong and trusted partner when making strategic regulatory decisions

Starodub was founded in May 2014. The company started with one employee, the founder Valentyna Starodub. By today, our team has grown to round 20 employees and has a valuable network of specialised experts. We partner with (bio)pharmaceutical and medical device companies worldwide to ensure that regulatory requirements are met and business goals, such as quick market access and compliance, are achieved.

The Starodub team, provides key expertise for ATMPs in Discovery and Early Development Stage. Their core team of experts is highly effective crafting the right messages and in engaging with authorities in a very effective format. They have been pivotal to ensure success and enable to deliver the necessary inflection points for the CAR-T programs of Cellula Therapeutics!

Ermir Kalaj, CEO

Cellula Therapeutics

What others have to say about us

Expertise guaranteed

Want to know more?

Learn how we can benefit you.

Let's Collaborate

Ready To Partner With Us?

Inquiries, Questions, Ideas? Contact Us.

Contact Us Directly

Any Other Questions? Feel Free to Reach Out To Us. 

Work With Us

Send Us An Email

Stay up-to-date

Read our latest posts

No ASMF Procedure for Biological Drug Substances? Here’s What You Need to Know

Human Medicines in 2024 (overview)

FDA Updated Guidance on Nitrosamine Impurities

Valentyna Starodub
Founder and Chief Executive Officer
Valentyna Starodub

Let's Connect

Talk to an expert